Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Quality Generic Drugs Here Buy Without Prescription Global Shipping

(Page 1) | 2 | newer

    0 0

    Drugs.com, the leading online clinical drug resource, today released third quarter 2012 United States prescription sales data for the top 100 drugs

    0 0

    Drugs.com, the leading online clinical drug resource, today released third quarter 2012 United States prescription sales data for the top 100 drugs

    0 0

    Drugs.com, the leading online clinical drug resource, today released third quarter 2012 United States prescription sales data for the top 100 drugs

    0 0

    Drugs.com, the leading online clinical drug resource, today released third quarter 2012 United States prescription sales data for the top 100 drugs

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily liquid Attention Deficit Hyperactivity Disorder treatment in the United States Quillivant XR...

    0 0

    Phased study to evaluate safety and efficacy of MK-8931 in patients with mild-to-moderate Alzheimer's disease WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Dec 3, 2012 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced it...

    0 0

    WHITEHOUSE STATION, N.J. & PRINCETON, N.J.--(BUSINESS WIRE)--Dec 18, 2012 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and GE Healthcare today announced a clinical study collaboration, license and supply agreement for...

    0 0

    Orion Corporation ("Orion") and Mylan Pharmaceuticals Inc. ("Mylan") have executed a settlement agreement on lawsuit filed by Orion in the United States against Mylan regarding Mylan's submission of abbreviated new drug application ("ANDA") for..

    0 0

    The Humane Society of the United States welcomes the pharmaceutical company’s decision

    0 0

    WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jan 11, 2013 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the company is taking steps to suspend the availability of TREDAPTIVE™...

    0 0

    NEW YORK--(BUSINESS WIRE)--Jan 31, 2013 - Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE

    0 0

    Merck Confirms 2013 Full-Year Guidance and Provides Guidance on First Quarter WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Feb 13, 2013 - Merck, known as MSD outside the United States and Canada, said today that it has completed a preliminary...

    0 0

    The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J., February 14, 2013 --(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle...

    0 0

    The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J., February 14, 2013 --(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle...

(Page 1) | 2 | newer